EUDA Health price target lowered to $2.75 from $6 at Greenridge

2 hours ago 2

Skip to navigation Skip to main contented Skip to close file

TipRanks

Tue, March 10, 2026 astatine 9:00 AM CDT 1 min read

Greenridge expert William Gregozeski lowered the firm’s price target connected EUDA Health (EUDA) to $2.75 from $6 and keeps a Buy standing connected the shares. The steadfast updated its exemplary for a simplification of Helixe bottles sold successful 2026, decreasing to 50,000 from 105,000, which reduced its gross estimation to $27.23M from $43.05M. It besides added successful the 12.5M shares that were issued successful precocious February, which had a dilutive effect connected its EPS estimates, the expert tells investors.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected EUDA:

Disclaimer & DisclosureReport an Issue

EUDA Health Repurchases Streeterville Warrant and Amends Charter to Clarify Share Actions
EUDA Health announces repurchase, cancellation of Streeterville warrant
EUDA Health Raises $3.75 Million and Retires Dilutive Warrant successful February 2026 Capital Moves
EUDA Health Lowers Streeterville Warrant Exercise Price to Align With Market Conditions
EUDA Health announces 2nd amendment to Streeterville warrant agreement

Read Entire Article